Other risk factors for PCP in the pre-ART (Anti-retroviral therapy) era were CD4 cell percentage <14%, previous episodes of PCP, oral thrush, recurrent bacterial pneumonia, unintentional weight loss, and higher plasma HIV RNA levels [5,6]. This evidence concerns the gene CD4 and pneumocystosis.